G protein-coupled receptors (GPCR) play an important role in signaling cascades, where they participate in the transduction of extracellular signals to intracellular heterotrimeric guanyl nucleotide binding proteins (G proteins). GPCRs are a large superfamily with a structure comprising an extracellular amino terminus, seven transmembrane-spanning α-helices connected by alternating extracellular and intracellular loops, and a cytoplasmic carboxyl terminal region.
Introduction
G protein-coupled receptors (GPCR) play an important role in signaling cascades, where they participate in the transduction of extracellular signals to intracellular heterotrimeric guanyl nucleotide binding proteins (G proteins). GPCRs are a large superfamily with a structure comprising an extracellular amino terminus, seven transmembrane-spanning α-helices connected by alternating extracellular and intracellular loops, and a cytoplasmic carboxyl terminal region. 1 The arrangement of the seven transmembrane-spanning helices and the extracellular domains provides a specific binding site for ligands, which induces a conformational change in the receptor that exposes intracellular regions, which recruit and activate G proteins.
The type 1 angiotensin II (AngII) receptor (AT1A) is a 359 amino acid GCPR that mediates the important cardiovascular and homeostatic actions of the peptide hormone angiotensin II. The 54 amino acid intracellular carboxyl terminus (Leu 305 to Glu 359 ) of the AT1A receptor interacts with G proteins 2 and other signaling molecules, 3 indicating a contribution to receptor activation, while the discovery of phosphorylation sites 4 and internalization motifs [5] [6] [7] suggest an involvement in receptor regulation. In particular, the proximal region (Leu 305 to Pro 321 ), comprising the first third of the AT1A receptor carboxylterminus, is an important site of complex interactions for receptor function.
In previous work, we proposed that the proximal carboxylterminus of the AT1A receptor (residues 305 -320) is an amphipathic α-helix (now referred to as helix VIII), and that this structure may be relevant to receptor activation and internalization on the basis of computer modeling. 6, 8, 9 In order to investigate the conformation and orientation of the proximal carboxyl terminus, the interaction of a synthetic peptide corresponding to the carboxyl terminus (Leu 305 to Lys 325 ) of the receptor (AT peptide) and its analogue peptide (where lysine residues at 307, 308, 310, and 311 were substituted with norleucine) with a zwitterionic or anionic lipid membrane as a model was examined by surface plasmon resonance (SPR). 8 The AT peptide was shown by SPR to bind with high affinity to a negatively charged lipid membrane via electrostatic interactions.
We have already established an evaluation method of the interactions of various peptides to lipid membranes using SPR, [9] [10] [11] [12] [13] [14] [15] and demonstrated that the kinetic rate constants and the affinity of membrane interactions can be readily determined by this technique, which in turn provides important insights into the mechanism of peptide-membrane interactions. In the present study, we extended our studies into the membrane binding properties of the AT peptide.
Specifically, we examined the membrane-binding properties of a series of peptide analogues of the AT peptide in which particular amino acid residues have been modified to establish their role in the structure and membrane binding. We determined the kinetic rate constants and affinity of these synthetic peptides to three model lipid membrane, which mimic a mammalian cell, and provided further insight in to the conformational and membrane binding properties of the proximal carboxyl-terminal region of the AT1A receptor.
Experimental

Chemicals and reagents
Dimyristoyl-L-α-phosphatidylcholine (DMPC) and
, and cholesterol were purchased from Sigma Chemical Co. (St Louis, MO, USA). Water was distilled and deionized in a Milli-Q system (Millipore, Bedford, MA, USA). A peptide corresponding to amino acid 305 -325 of the AT1A receptor (AT) and its four analogue peptides were purchased from Mimotopes (Clayton, Australia). The sequence and molecular weight of the AT peptide and the peptide analogues used in this study are listed in Table 1 .
Apparatus
The SPR system used was a BIACORE 3000 analytical system (Biacore, Uppsala, Sweden) using the L1 sensor chip (Biacore) for liposome attachment. The running buffers used for estimating the interaction of the peptides to the membrane were a 20 mmol/l phosphate buffer (pH 6.8) containing 150 mmol/l sodium chloride for AT, QIA and LGK, or a 20 mmol/l phosphate buffer (pH 6.8) containing 150 mmol/l sodium chloride/dimethylsulfoxide (DMSO) (99:1 v/v) for LGA and LFY. For immobilizing lipid membranes on a chip, a 20 mmol/l phosphate buffer (pH 6.8) containing 150 mmol/l sodium chloride was used. The washing solution was 20 mmol/l CHAPS and the regeneration solution was 10 mmol/l sodium hydroxide. All of the solutions were freshly prepared, degassed and filtered through a 0.22 µm filter.
Liposome preparation
In this study, DMPC, DMPC/DMPG ( 
Formation of lipid bilayer membranes
The L1 sensor chip surface was washed by the injection of 5 µL of 20 mmol/l CHAPS at a flow rate of 5 µl/min. SUVs (80 µl) were immediately applied to the sensor chip at a flow rate of 2 µl/min for liposome capture. To remove any multilamellar structures from the lipid surface, 30 µl of 10 mmol/l sodium hydroxide was injected at a flow rate of 50 µl/min, which resulted in a stable baseline corresponding to the supported lipid bilayer.
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Peptide binding to the bilayer membrane
Peptide solutions for AT, QIA and LGK were prepared by dissolving each peptide in a 20 mmol/l phosphate buffer (pH 6.8) containing 150 mmol/l sodium chloride to give peptide concentrations from 10 to 100 µmol/l.
LGA was dissolved in a 20 mmol/l phosphate buffer (pH 6.8) containing 150 mmol/l sodium chloride/DMSO (99:1, v/v) to give a concentration ranging from 1 to 10 µmol/l. Similarly, LFY was 20 mmol/l phosphate buffer (pH 6.8) containing 150 mmol/l sodium chloride/DMSO (99:1, v/v) to give final concentrations from 1 to 4.5 µmol/l. For LGA and LFY, the inclusion of 1% DMSO was required to maintain the solubility of peptide solutions and to obtain the desired sensorgrams for the kinetic study in the present work. The peptide solution (30 µl, 120 s) was injected over the lipid surface at a flow rate of 15 µl/min to avoid limitation by mass transfer. Upon completion of injection, buffer flow was continued to allow a dissociation time of 600 s. All binding experiments were carried out at 25˚C. The affinity of each peptide for the lipid bilayer membrane was determined from the analysis of a series of response curves collected at seven different peptide concentrations injected over each lipid surface. It was also confirmed in the present study that the running buffer with or without DMSO did not affect the kinetic binding analysis using AT peptide, indicating that the kinetics for all peptides could be simultaneously estimated.
The sensorgrams for each peptide-lipid interaction were analyzed by curve fitting using numerical integration analysis. [16] [17] [18] [19] [20] [21] [22] [23] The data were fitted globally by simultaneously fitting the peptide sensorgrams obtained at seven different concentrations using BIA evaluation software (Ver 4.1). The two-state reaction model was applied to the resultant peptide binding curves to estimate the association and dissociation rate constants. This model was chosen based on previous studies of peptides-membrane interaction. [9] [10] [11] [12] [13] [14] [15] [24] [25] [26] [27] 
Results and Discussion
Design of peptide analogues
In order to explore the membrane-binding properties of the AT peptide, we designed and synthesized four analogue peptides with modified amino acid sequences, as shown in Table 1 .
The QIA peptide had the same amino acid composition as the AT peptide, but the sequence was scrambled to abrogate amphipathicity. The LGK peptide contained alanine substitutions at tyrosine 312, phenylalanine 313, and leucine 314, since these residues have been proposed to be involved in membrane anchoring. 7 The LGA peptide contained substitutions of lysine residues at 307, 308, 310, and 311 with alanine to investigate the role of charge in peptide structure and binding. These lysine residues have been shown to be important for receptor expression and for G protein binding. 7, 28 The LFY peptide was in effect a frameshift of the AT peptide corresponding to amino acid residues 300 -320 of the AT1A receptor, which included the last 5 residues of the 7th transmembrane domain. 7 The affinity of membrane-binding for these peptide analogues, including the AT peptide, were then estimated by SPR. Figure 1 shows representative sensorgrams of the peptides binding to the immobilized lipid membranes. In all cases, there was a proportional increase in the response with increasing peptide concentration, indicating that the system has not reached saturation. The association (ka1, ka2) and dissociation (kd1, kd2) rate constants and the affinity constant (K) estimated by the two-state reaction model are listed in Table 2 . This model was selected based on multi-step model of peptide-lipid interactions, and provided a superior fit to the data than the simpler 1:1 binding model. As previously discussed, the first step of the two-state model may involve an initial electrostatic interaction, followed by a reorientation and/or insertion of the peptide into the hydrophobic interior (step 2).
Binding property of AT and analogue peptides to lipid membranes by SPR
9-13
The affinity of the AT peptide for DMPC/DMPG or DMPC/DMPG/cholesterol was higher than that of DMPC, which could be attributed to a higher rate of the electrostatic interaction (ka1), which is mediated by the interaction between the cationic lysine residues and the anionic head group of DMPG.
The binding of QIA to the lipid membranes was lower than that observed for AT for all lipids, and exhibited a significantly lower association rate constant for step 1 (ka1), corresponding to a weaker electrostatic interaction. The lower affinity suggests that the scrambled sequence prevents the formation of a helical structure in all lipid mixtures (data not shown), and indicates the importance of the wild-type sequence in maintaining the structure and promoting membrane binding.
The affinity of LGK for all lipid membranes was lower than those for AT, which could be attributed to a lower rate of hydrophobic association (ka2) (i.e. step 2). Moreover, the rate constants for electrostatic association (ka1) were similar to that of the AT peptide, which is consistent with the fact that LGK contains the same number of lysine residues as the AT peptide. The results suggest that the alanine substitutions at tyrosine 312, phenylalanine 313 and leucine 314 significantly decreased the membrane anchoring, resulting in a lower overall membrane affinity.
The effect of substituting four lysine residues in AT to give LGA had different effects for each lipid mixture. Compared to AT, LGA had a higher affinity for DMPC, a lower affinity for DMPC/DMPG, and a similar affinity for DMPC/DMPG/cholesterol. These changes in binding can all be attributed to a decrease in the number of positively charged amino acids, which suggests that four lysine residues are critical for the binding of AT peptide to the lipid membranes. This is most clearly evident concerning the 10-fold decrease in the ka1 value for DMPC/DMPG, reflecting a significant decrease in the electrostatic interactions between the peptide and the anionic phospholipids. We have previously hypothesized that alanine substitutions at positions 307, 308, 310 and 311 would interact with the membrane via a hydrophobic interaction around the occurring electrostatic interaction, and that this hydrophobic interaction would prevent the dissociation of the peptide from the membrane surface.
Finally, a kinetic analysis of the sensorgrams for LFY demonstrated a significantly increased affinity compared to the AT peptide. The main kinetic changes that lead to this overall increase in affinity were a decreased ka1 and a large decrease in kd2. These results are consistent with the inclusion of part of the last five residues of the 7th transmembrane, leading to a significantly slower dissociation from membranes via the hydrophobic interaction.
Conclusion
In the present study, we examined the interactions of the 173 ANALYTICAL SCIENCES FEBRUARY 2005, VOL. 21 synthetic AT peptide and a series of peptide analogues containing modified amino acid sequences, with three model lipid membranes. The results demonstrated the role of key amino acid residues, providing insight into the membranebinding properties of the AT peptide. In particular, the importance of four, clustered lysine residues in electrostatic interactions was revealed, with the AT peptide showing the highest affinity for DMPG-containing membranes containing a negatively charged phospholipid rather than a zwitterionic phospholipid. The selective affinity of the AT peptide to the lipid membrane may be crucial for the binding of G proteins and subsequent cell signalling by G protein activation. These studies provide a basis for further investigations into the interactions of the AT peptide with lipid membranes and G proteins related to activation of the AT1A receptor. The approach described here could also be useful to estimate the interactions of the intracellular regions of other GPCRs with lipid membranes.
